How Has the Tissue Sectioning Market Size Evolved in Recent Years?
The tissue sectioning market has seen considerable growth due to a variety of factors.
• The tissue sectioning market has grown rapidly in recent years, expected to increase from $0.76 billion in 2024 to $0.83 billion in 2025, at a CAGR of 10.2%.
Growth drivers include the increasing prevalence of chronic diseases, an aging population, investments in life sciences research, expanding biotech and pharmaceutical industries, and greater awareness about early disease detection.
What Are The Predictions for The Tissue Sectioning Market in the Coming Years?
The tissue sectioning market is expected to maintain its strong growth trajectory in upcoming years.
• The tissue sectioning market is projected to grow to $1.21 billion by 2029 at a CAGR of 9.9%.
Growth drivers include the demand for personalized medicine, biobank growth, and rising healthcare expenditures. Trends include advancements in automation, integration of AI, the use of 3D tissue sectioning, and improvements in imaging and cryosectioning techniques.
Which Drivers Are Accelerating Growth In The Tissue Sectioning Market?
The growth of the tissue sectioning market is projected to be fueled by the increasing number of surgical procedures. Surgical procedures, which are medical actions that employ instruments for diagnosing, treating, or mending the body, are on the rise due to advancements in medical technology, shifting demographics, and changes in healthcare practices. Tissue sectioning supports these surgical procedures by supplying precise, thin slices of tissue for histological examination, which allows for accurate diagnoses, treatment planning, and transplants. The Australian Institute of Health and Welfare (AIHW), a governmental agency for public health and welfare in Australia, reported in December 2023 that there were 735,500 patients admitted for surgery from public hospital elective surgery waiting lists in 2022–23, an increase of 18% from 2021–22. Thus, the increasing number of surgical procedures is propelling the tissue sectioning market.
What Are The Core Segments Of The Global Tissue Sectioning Market?
The tissue sectioning market covered in this report is segmented –
1) By Product: Accessories And Consumables, Instruments, Services
2) By Technology: Automatic, Manual, Semi-Automatic
3) By Application: Diagnosis, Research
4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers
Subsegments:
1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)
2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems
3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services
Pre-Book The Tissue Sectioning Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Tissue Sectioning Market?
Major firms in the tissue sectioning market are pioneering innovative technologies, such as next-gen spatial gene expression technology, to improve tissue examination and diagnostics. This advanced technology helps create a detailed blueprint of gene activity in tissue sections, shedding light on gene expression and tissue architecture’s spatial layout. For instance, in March 2024, 10x Genomics, a biotechnology company based in the US, introduced the Visium HD. This is a cutting-edge spatial gene expression technology that facilitates the precise mapping of gene expression within intricate anatomical formations. It is specifically designed to provide high-resolution gene expression data from formalin-fixed, paraffin-embedded (FFPE) tissue sections on a single cell scale. This technology paves the way for an exhaustive characterization of FFPE tissue sections by recording entire transcriptome spatial gene expression at single-cell resolution.
Who Are the Key Players In The Tissue Sectioning Market?
Major companies operating in the tissue sectioning market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Labcorp Drug Development
• Agilent Technologies Inc.
• Leica Biosystems Nussloch GmbH
• Abcam Limited
• Sakura Finetek USA Inc.
• Ted Pella Inc.
• Santa Cruz Biotechnology Inc.
• Milestone Srl
• Diapath S.p.A.
• Bio-Optica Milano S.p.A
• MEDITE Medical GmbH
• PathnSitu Biotechnologies Pvt Ltd
• Tanner Scientific Inc.
• Boeckeler Instruments Inc.
• SLEE Medical GmbH
• Amos Scientific PTY. LTD.
• LLS ROWIAK LaserLabSolutions GmbH
• SM Scientific Instruments Pvt. Ltd.
• Bright Instrument Co. Ltd.
• RWD Life Science Co. Ltd.
• Hacker Instruments & Industries Inc.
What Are The Regional Insights Into The Tissue Sectioning Market?
North America was the largest region in the tissue sectioning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
